Literature DB >> 14610218

Kinetic study on the reactions of platinum drugs with glutathione.

Douglas Hagrman1, Jerry Goodisman, Abdul-Kader Souid.   

Abstract

The binding of platinum (Pt) drugs (oxaliplatin, carboplatin, and cisplatin) to glutathione (GSH, 6.75 mM) was investigated at 37 degrees C in Hepes (100 mM, pH approximately 7.4) or Tris-NO(3) (60 mM, pH 7.4) buffer and NaCl (4.62, 6.63, or 7.82 mM). The conditions were chosen to mimic passage of clinical concentrations of the drugs (135 microM) through the cytosol. The reactions were monitored by UV-absorption spectroscopy, high-performance liquid chromatography (HPLC), and atomic absorption spectroscopy. The initial rates, detected by UV absorbance, were similar for oxaliplatin and cisplatin reacting with GSH and were more than 5-fold faster than for carboplatin reacting with GSH. The Pt contents in HPLC eluates corresponding to unbound drug decreased exponentially with time, confirming that the reactions were first order in [Pt drug] and allowing determination of the pseudo first-order rate constants (k(1)). The second-order rate constants (k(2)) were calculated as k(1) divided by [GSH]. The k(2) value for oxaliplatin reacting with GSH was approximately 3.8 x 10(-2) M(-1) s(-1), for cisplatin reacting with GSH approximately 2.7 x 10(-2) M(-1) s(-1), and for carboplatin reacting with GSH approximately 1.2 x 10(-3) M(-1) s(-1) (approximately 32-fold slower than that of oxaliplatin and approximately 23-fold slower than that of cisplatin). These results demonstrate an influence of ligands surrounding the Pt coordination sphere on the reactivity of Pt(2+) with GSH.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14610218     DOI: 10.1124/jpet.103.059410

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Preferential energy- and potential-dependent accumulation of cisplatin-gutathione complexes in human cancer cell lines (GLC4 and K562): A likely role of mitochondria.

Authors:  Simplice Dzamitika; Milena Salerno; Elene Pereira-Maia; Laurence Le Moyec; Arlette Garnier-Suillerot
Journal:  J Bioenerg Biomembr       Date:  2006-05-27       Impact factor: 2.945

2.  Formation of chelate structure between His-Met dipeptide and diaqua-cisplatin complex; DFT/PCM computational study.

Authors:  Michal Maixner; Helio F Dos Santos; Jaroslav V Burda
Journal:  J Biol Inorg Chem       Date:  2018-02-08       Impact factor: 3.358

3.  In vitro effects of platinum compounds on renal cellular respiration in mice.

Authors:  Saeeda-S Almarzooqi; Ali-S Alfazari; Hidaya-M Abdul-Kader; Dhanya Saraswathiamma; Alia-S Albawardi; Abdul-Kader Souid
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

4.  Allantoin reduces cell death induced by cisplatin: possible implications for tumor lysis syndrome management.

Authors:  Janaina Fernandes; Gisele Cardoso de Amorim; Tallita Eduarda da Veiga; Jesiel Cardoso; Alberto Cardoso Arruda; Mara Silvia Pinheiro Arruda; Morgana T L Castelo-Branco
Journal:  J Biol Inorg Chem       Date:  2019-04-27       Impact factor: 3.358

5.  Effect of reactivity on cellular accumulation and cytotoxicity of oxaliplatin analogues.

Authors:  Irina Buß; Ganna V Kalayda; Andreas Lindauer; Michael R Reithofer; Markus Galanski; Bernhard K Keppler; Ulrich Jaehde
Journal:  J Biol Inorg Chem       Date:  2012-03-29       Impact factor: 3.358

6.  ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia.

Authors:  S H Tonino; J van Laar; M H van Oers; J Y Wang; E Eldering; A P Kater
Journal:  Oncogene       Date:  2010-10-11       Impact factor: 9.867

7.  The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin.

Authors:  Nataliya V Dolgova; Doug Olson; Svetlana Lutsenko; Oleg Y Dmitriev
Journal:  Biochem J       Date:  2009-04-01       Impact factor: 3.857

8.  Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin.

Authors:  Christina Peklak-Scott; Pamela K Smitherman; Alan J Townsend; Charles S Morrow
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

9.  The impact of different chelating leaving groups on the substitution kinetics of mononuclear Pt(II)(1,2-trans-R,R-diaminocyclohexane)(X-Y) complexes.

Authors:  Nadine Summa; Tanja Soldatović; Lutz Dahlenburg; Zivadin D Bugarcić; Rudi van Eldik
Journal:  J Biol Inorg Chem       Date:  2007-01-24       Impact factor: 3.862

10.  Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11.

Authors:  Ross M Drayton; Ewa Dudziec; Stefan Peter; Simone Bertz; Arndt Hartmann; Helen E Bryant; James Wf Catto
Journal:  Clin Cancer Res       Date:  2014-02-10       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.